Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 32.91
-0.15 (-0.45%)
Sep 1, 2026, 4:00 PM EDT
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 3.26 billion as of September 1, 2026. Its market cap has decreased by -45.25% in one year.
Market Cap
3.26B
Enterprise Value
2.58B
Revenue
62.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.91
ChartMarket Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 3.26B, an increase of 9.34%. That is a compound annual growth rate of 2.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 3.26B | -33.07% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
| Apr 12, 2022 | 2.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lifecome Biochemistry | 3.62B |
| Pulike Biological Engineering | 3.61B |
| Shanghai Shen Lian Biomedical | 3.42B |
| Jiangsu Bioperfectus Technologies | 3.41B |
| Qingdao Vland Biotech INC. | 3.31B |
| Baolingbao Biology | 3.21B |
| Shanghai Model Organisms Center | 3.13B |
| Guanhao Biotech | 3.10B |